Relay Therapeutics Stock Forecast

Stock Price Forecast

According to 14 analysts polled by S&P Global, Relay Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $27.08. The average 1-year stock price forecast is 43.74% higher than the current stock price, while the lowest is $20 (+6.16%) and the highest is $32 (+69.85%).

Price Target: $27.08 (+43.74%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$20	$27.08	$26	$32
Change	+6.16%	+43.74%	+38.00%	+69.85%

Analyst Ratings

The average analyst rating for Relay Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Mar '26	Apr '26	May '26	Jun '26	Jul '26	Aug '26
Strong Buy	10	10	11	10	11	11
Buy	2	2	2	2	3	3
Hold	0	1	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	13	13	12	14	14

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns H.C. Wainwright	H.C. Wainwright	Buy Reiterates $28 → $29	Buy	Reiterates	$28 → $29	+53.93%	Aug 20, 2026
Priyanka Grover J.P. Morgan	J.P. Morgan	Buy Maintains $28 → $31	Buy	Maintains	$28 → $31	+64.54%	Aug 14, 2026
Silvan Tuerkcan Citizens JMP	Citizens JMP	Buy Maintains $21 → $26	Buy	Maintains	$21 → $26	+38.00%	Aug 10, 2026
John Newman Canaccord Genuity	Canaccord Genuity	Buy Maintains $29	Buy	Maintains	$29	+53.93%	Aug 7, 2026
Boris Peaker JonesTrading	JonesTrading	Buy Maintains $20	Buy	Maintains	$20	+6.16%	Aug 7, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

7.91M

from 15.36M

-48.49%

from 15.36M

Revenue Next Year

16.53M

from 7.91M

109.03%

from 7.91M

EPS This Year

-1.63

from -1.61

EPS Next Year

-1.64

from -1.63

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	3.03M	1.38M	25.55M	10.01M	15.36M	7.91M
Revenue Growth	-96.34%	-54.41%	1,749.82%	-60.83%	53.44%	-48.49%
Operating Income	-226.11M	-310.95M	-379.42M	-385.67M	-300.44M	-348.34M
Net Income	-363.87M	-290.51M	-341.97M	-337.71M	-276.48M	-323.03M
EPS	-	-	-	-	-1.61	-1.63
Free Cash Flow	-8.17M	-108.60M	-183.52M	-131.63M	-141.28M	-290.56M
No. Analysts	-	-	-	-	-	12

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	30.6M
Avg	7.9M
Low	3.0M

Revenue Growth

Chart

Revenue Growth	2026	2027	2028
High	99.3%
Avg	-48.5%
Low	-80.5%

EPS Forecast

Chart

EPS	2026	2027	2028
High	-1.56
Avg	-1.63
Low	-1.72

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-